Stock ALVAL VALBIOTIS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus VALBIOTIS

Equities

ALVAL

FR0013254851

Market Closed - Euronext Paris
Other stock markets
 11:35:02 2024-04-30 EDT 		5-day change 1st Jan Change
4.11 EUR +4.31% Intraday chart for VALBIOTIS +6.06% -17.80%
04-26 Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-03 Valbiotis: launch of Valbiotis PRO Cholesterol in May CF

Evolution of the average Target Price on VALBIOTIS

Price target over the last 5 years

History of analyst recommendation changes

1cd6cb68473121af2d3b96b59718.W78T6PH5iCRsOEExx0S762eazjm3x2q21LbK_6WIKNQ.LfYn2IDK0GglZ3dArCDI2wvXmF3691uFn9W5nZ3mWOQYzHeYiZa_SxxfMg~0e9d40350249330014daa8459483ca9f

Analyst Recommendations on VALBIOTIS

VALBIOTIS : Invest Securities confirms its recommendation CF
Valbiotis: share price up, broker in support CF
VALBIOTIS : Oddo BHF raises its target price CF
Valbiotis: share price soars, broker adjusts target CF
VALBIOTIS : promising study, Invest Sec. raises its target CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.11 EUR
Average target price
10.07 EUR
Spread / Average Target
+144.93%
High Price Target
11.8 EUR
Spread / Highest target
+187.10%
Low Price Target
9.2 EUR
Spread / Lowest Target
+123.84%

Consensus detail

Consensus revision (last 18 months)

Ratings for VALBIOTIS

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALVAL Stock
  4. Consensus VALBIOTIS